Cargando…
A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma
BACKGROUND: There is a heterogenous clinical response following chemoradiotherapy (CRT) in esophageal squamous cell carcinoma (ESCC). Therefore, we aimed to study signaling pathway genes that affect CRT sensitivity and prognosis. METHODS: Gene expression analyses were performed in the GEO and TCGA d...
Autores principales: | Zhang, Zewei, Liu, Shiliang, Gao, Tiantian, Yang, Yuxian, Li, Quanfu, Zhao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441524/ https://www.ncbi.nlm.nih.gov/pubmed/37609436 http://dx.doi.org/10.7717/peerj.15839 |
Ejemplares similares
-
A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2019) -
An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma
por: Zheng, Zhuotao, et al.
Publicado: (2021) -
Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022) -
Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes
por: Xu, Chengbo, et al.
Publicado: (2023) -
A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2021)